Its role in cancer is particularly noteworthy, as menin serves as a tumor suppressor in neuroendocrine cancers [2,3] but can act as a contextual tumor promoter in prostate cancer, MLL-fusion leukemia, and now CRC [4,5]. The gene discussed is KMT2A; the disease is neuroendocrine carcinoma.